Coya Therapeutics is working On neurodegenerative disease treatment with its combination therapies targeting regulatory T cells. CEO Howard Berman discusses the potential of COYA 302 for ALS, FTD, Parkinson's, and Alzheimer's, emphasizing a transformative approach to immune balance restoration.
McGuire Investment Group LLC reduced its stake in Invesco S&P SmallCap Health Care ETF (NASDAQ:PSCH – Free Report) by 3.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 34,934 shares of the company’s stock after selling 1,401 shares during the period. McGuire Investment […]
Raymond James Financial Services Advisors Inc. grew its position in Invesco S&P SmallCap Health Care ETF (NASDAQ:PSCH – Free Report) by 178.0% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 19,647 shares of the company’s stock after buying an additional 12,579 shares during the period. Raymond James […]